For the Inventor, By the Inventor

Enter assignee name

Warszawski Uniwersytet Medyczny

USPTO Granted Patents = 12

CIPO Patents = 1

EPO Patents = 23

Forward Citations = 1

Loading Chart...

Loading Chart...

60 inventors (with patents filed for the assignee):

Szczepan Mogilski (3 out of 3 patents)

Gniewomir Latacz (3 out of 3 patents)

Anna Rapacz (3 out of 3 patents)

4. Michal Abram (3 out of 3 patents)

5. Krzysztof Kaminski (3 out of 3 patents)

6. Krzysztof Mucha (2 out of 2 patents)

7. Leszek Paczek (2 out of 2 patents)

8. Radoslaw Zagozdzon (2 out of 2 patents)

9. Bartosz Foroncewicz (2 out of 2 patents)

10. Michal Dadlez (2 out of 2 patents)

11. Oliwia Zegrocka-Stendel (2 out of 5 patents)

12. Grzegorz Grynkiewicz (2 out of 4 patents)

13. Mariusz Marek Gruza (2 out of 2 patents)

14. Kamil Jatczak (2 out of 3 patents)

15. Marta Laszcz (2 out of 3 patents)

12 patents: Sort by Forward Citations

1. 12449426 - Method of screening for a chronic kidney disease or glomerulopathy method of monitoring a response to treatment of a chronic kidney disease or glomerulopathy in a subject and a method of treatment of a chronic kidney disease or glomerulopathy (2025-10-21),

2. 12421189 - Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders (2025-09-23),

3. 12331019 - Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders (2025-06-17),

4. 12139458 - (2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide derivatives and their use in the treatment of neurological diseases (2024-11-12),

5. 11029314 - Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy (2021-06-08),

6. 10702633 - Method of manufacturing intramedullary nails made of chitosan for long bones fractures treatment (2020-07-07),

7. 10370404 - Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound (2019-08-06),

8. 9850467 - Methods of using T4 bacteriophage in treatment of adenoviral infections caused by HAdV-5 (2017-12-26),

9. 9682056 - Oleacein for treating or preventing diseases resulting from atherosclerotic plaques (2017-06-20),

10. 9101577 - Analgesic pharmaceutical composition for oral administration (2015-08-11),

11. 9073813 - Process for the preparation of protoescigenin (2015-07-07),

12. 9018255 - Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase system (2015-04-28),

Warsaw Medical University is one of the leading medical schools in Poland, offering a wide range of medical programs and cutting-edge research opportunities. With a history dating back to 1809, the university has a strong reputation for excellence in medical education and healthcare. Its mission is to provide high-quality education, research, and healthcare services to improve the health and well-being of society.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

12 Patents

#7 in Warsaw

#27 in Poland

#46,685 in the World

Warszawski Uniwersytet Medyczny

Forward Citations = 1

60 inventors:

Szczepan Mogilski (3 out of 3 patents)

Gniewomir Latacz (3 out of 3 patents)

Anna Rapacz (3 out of 3 patents)

4. Michal Abram (3 out of 3 patents)

5. Krzysztof Kaminski (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…